James Wooldridge

Chief Tech/Sci/R&D Officer en CHECKMATE PHARMACEUTICALS, INC. .

58 años

Health Technology

Consumer Services

Perfil

James Wooldridge is currently the Chief Medical Officer at Checkmate Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Spyre Therapeutics, Inc. from 2017 to 2019 and as the Chief Scientific Officer at Eli Lilly & Co. He received his doctorate degree from Tulane University in 1992 and his undergraduate degree from William Jewell College in 1988.

Cargos activos de James Wooldridge

Empresas	Cargo	Inicio
CHECKMATE PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/10/2019

Todos los cargos activos de James Wooldridge

Antiguos cargos conocidos de James Wooldridge.

Empresas	Cargo	Fin
SPYRE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	10/10/2019
ELI LILLY AND COMPANY	Corporate Officer/Principal	-

Ver el detalle de la experiencia de James Wooldridge.

Formación de James Wooldridge.

Tulane University (Louisiana)	Doctorate Degree
William Jewell College	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de James Wooldridge.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ELI LILLY AND COMPANY	Health Technology
SPYRE THERAPEUTICS, INC.	Health Technology

Empresas privadas	1
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology